You are here » Home » Companies » Company Overview » Brooks Laboratories Ltd

Brooks Laboratories Ltd.

BSE: 533543 Sector: Health care
NSE: BROOKS ISIN Code: INE650L01011
BSE LIVE 15:40 | 16 Aug 108.75 3.60
(3.42%)
OPEN

108.00

HIGH

110.00

LOW

106.00

NSE 15:47 | 16 Aug 109.05 3.30
(3.12%)
OPEN

105.90

HIGH

110.00

LOW

105.90

OPEN 108.00
PREVIOUS CLOSE 105.15
VOLUME 10538
52-Week high 194.40
52-Week low 96.00
P/E 89.88
Mkt Cap.(Rs cr) 176
Buy Price 108.75
Buy Qty 6.00
Sell Price 0.00
Sell Qty 0.00
OPEN 108.00
CLOSE 105.15
VOLUME 10538
52-Week high 194.40
52-Week low 96.00
P/E 89.88
Mkt Cap.(Rs cr) 176
Buy Price 108.75
Buy Qty 6.00
Sell Price 0.00
Sell Qty 0.00

Brooks Laboratories Ltd. (BROOKS) - Company History

Brooks Laboratories Ltd is a Pharmaceutical Contract Research & Manufacturing Services company. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc. Their product portfolio presently comprises of 28 Injectables, 19 Tablets and 2 Dry Syrups which are marketed domestically. The company has manufacturing facilities located at Baddi in Himachal Pradesh. Their manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes. Their Baddi facility is a WHO-GMP and ISO-9001:2008 certified. At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India. The company's major clients are companies like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd, Sanat Products Ltd, Hetero Healthcare Ltd, Medley Pharmaceuticals, Wockhardt Ltd, Parental Drugs, Chanderbhagat Pharma and Alembic Ltd etc. Their major suppliers of raw materials are Rajasthan Antibiotics Ltd, Aurobindo Pharma Ltd, DSM Anti Infectives Ltd and Qilu Pharmaceutical Company Ltd. Brooks Laboratories Ltd was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. In the year 2006, the company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development (R&D) centre at Baddi, Himachal Pradesh. In May 2006, they started their operations and in June 3, 2006, they commenced commercial production. In October 2006, the company obtained Import license from Drugs Controller General of India under the Drugs Act 1940 and Drugs Rules. In August 2007, they received an AS/NZS ISO 9001:2000 Certificate from SAI Global Certification Services Pty Ltd, Australia. In April 2008, the company took over some of the assets of Brooks Pharmaceuticals, a partnership firm of the promoters, Atul Ranchal & Rajesh Mahajan. In April 2010, the manufacturing facility at Baddi was certified as WHO GMP compliant by Department of Health & Family Welfare, HP. In July 2010, the company received an ISO 9001:2008 Certificate from UKAS Quality Management, URS & IAF. The company plans to set up a facility at JB SEZ, Panoli, Gujarat for manufacturing of various pharmaceuticals formulations in compliance with EU GMP Standards to cater to high end market of Europe, CIS & South Africa.